Suchergebnisse - "Vaughan, Heidi"

PubPharm (19)

1

Efficacy against pneumococcal carriage and the immunogenicity of reduced-dose (0 + 1 and 1 + 1) PCV10 and PCV13 schedules in Ho Chi Minh City, Viet Nam : a parallel, single-blind, randomised controlled trial

enthalten in: The Lancet. Infectious diseases | 2023

von Temple, B. | Tran, H. | Dai, V. | +22

CommentIn: Lancet Infect Dis. 2023 Aug;23(8):884-885. - PMID 37062299

2

Immunogenicity, otitis media, hearing impairment, and nasopharyngeal carriage 6-months after 13-valent or ten-valent booster pneumococcal conjugate vaccines, stratified by mixed priming schedules : PREVIX_COMBO and PREVIX_BOOST randomised controlled trials

enthalten in: The Lancet. Infectious diseases | 2022

von Leach, A. | Wilson, N. | Arrowsmith, B. | +18

3

Simplified 0+1 and 1+1 pneumococcal vaccine schedules in Ho Chi Minh City, Vietnam : protocol for a randomised controlled trial

enthalten in: BMJ open | 2021

von Temple, B. | Tran, H. | Dai, V. | +9

4

Effect of a 2+1 schedule of ten-valent versus 13-valent pneumococcal conjugate vaccine on pneumococcal carriage : Results from a randomised controlled trial in Vietnam

enthalten in: Vaccine | 2021

von Temple, B. | Nation, M. | Dai, V. | +16

5

Otitis media outcomes of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine and 13-valent pneumococcal conjugate vaccine schedule at 1-2-4-6 months : PREVIX_COMBO, a 3-arm randomised controlled trial

enthalten in: BMC pediatrics | 2021

von Leach, A. | Mulholland, E. | Santosham, M. | +9

6

Acute lower respiratory infections in Indigenous infants in Australia's Northern Territory across three eras of pneumococcal conjugate vaccine use (2006-15) : a population-based cohort study

enthalten in: The Lancet. Child & adolescent health | 2020

von Binks, M. | Beissbarth, J. | Oguoma, V. | +8

CommentIn: Lancet Child Adolesc Health. 2020 Jun;4(6):408-409. - PMID 32450118

7

10-Valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine (PHiD-CV10) versus 13-valent pneumococcal conjugate vaccine (PCV13) as a booster dose to broaden and strengthen protection from otitis media (PREVIX_BOOST) in Australian Aboriginal children : study protocol for a randomised controlled trial

enthalten in: BMJ open | 2020

von Oguoma, V. | Wilson, N. | Mulholland, K. | +16

8

Use of the 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) in an Australian Indigenous paediatric population does not alter the prevalence of nontypeable Haemophilus influenzae without the protein D gene

enthalten in: Vaccine | 2019

von Beissbarth, J. | Smith-Vaughan, H. | Harris, T. | +2

9

Evaluation of different infant vaccination schedules incorporating pneumococcal vaccination (The Vietnam Pneumococcal Project) : protocol of a randomised controlled trial

enthalten in: BMJ open | 2018

von Temple, B. | Toan, N. | Uyen, D. | +11

10

Reduced nontypeable Haemophilus influenzae lower airway infection in children with chronic endobronchial suppuration vaccinated with the 10-valent pneumococcal H. influenzae protein D conjugate vaccine

enthalten in: Vaccine | 2018

von Hare, K. | Smith-Vaughan, H. | Leach, A. | +3